News Focus
News Focus
Followers 24
Posts 4139
Boards Moderated 0
Alias Born 12/18/2019

Re: SkyLimit2022 post# 805696

Thursday, 01/01/2026 12:06:46 AM

Thursday, January 01, 2026 12:06:46 AM

Post# of 819911
I am -- That's why FDA has told NWBO not to bother filing a commercial application. Nobody else really matters. UK is not a financially viable market for NWBO to survive. Only U.S. market provides the scale and pricing for oncology developers to become financially successful. But it would take a compliant P3 trial.

Approval in UK won't make NWBO successful. Just continue as a Zombie Biotech.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News